3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Meningeal Neoplasms
1
Melanoma
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Genital Diseases
1
Fibrolamellar hepatocellular carcinoma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
9
Biopsy
5
Specimen Handling
4
Prednisone
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
fludarabine
3
Vincristine
3
Etoposide
3
Doxorubicin
3
Brentuximab Vedotin
3
sodium-iodide symporter
2
pembrolizumab
2
fludarabine phosphate
2
cemiplimab
2
alectinib
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Rituximab
2
Positron-Emission Tomography
2
Photons
2
Mycophenolic Acid
2
Immunoglobulin G
2
Filgrastim
2
Disulfides
2
Cyclosporine
2
10-propargyl-10-deazaaminopterin
2
treosulfan
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
sapanisertib
×
1 year
×
Clear all
No trials found.